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The aim and objectives of the study were to investigate the state of adsorption-rheological properties of blood (ARPB) in patients with 
different clinical course of lung cancer (LC), the detection of violations of surface-active, viscoelastic and relaxation properties of blood 
serum, their association with tumor markers, the evaluation of the prognostic value of initial indexes in the development of complica-
tions from radiochemotherapy. Patients and Methods: The study included 115 patients with LC at the age from 24 to 80 years (aver-
age age 58 years), among whom there were 78% men and 22% women. The parameters of surface (interfacial) viscosity, elasticity, 
viscoelasticity module, tension and relaxation of blood serum were studied by the oscillating drop method using a computer tensiometer 
“PAT2-Sinterface”, and its volumetric viscosity was investigated using a Low-Shear-30 rotational viscometer. ARPB parameters were 
also studied in a control group composed from 50 healthy donors. Results: Increased levels of volumetrical viscosity, surface tension, 
surface elasticity and the relaxation time of the blood are typical for patients with LC and depended on the localization of the tumor, its 
histological variant, differentiation grade, severity of the course of the disease, the number of metastases in the lymph nodes, distant 
organs and skeleton, involvement of the pleura and ribs, the development of compression pulmonary syndrome, metastasis into the 
spine, adrenals, brain, and pancreas. The surface-active, viscoelastic and relaxation properties of the blood correlated with the levels 
of tumor markers (TGFβ1, VEGF, C-reactive protein, α2-macroglobulin). Conclusions: Integral changes of ARPB observed in every 
fifth patient with LC are involved in the pathogenesis of the disease, have predictive value in relation to the clinical course of disease 
(volumetric viscosity) and the development of complications from radiochemotherapy (surface viscosity).
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Lung cancer (LC) is the leader in the structure 
of cancer morbidity and mortality [1, 2]. An impor-
tant pathogenetic link supporting the properties 
of LC is neoangiogenesis (the formation of new ves-
sels) [3]. At the same time, the expression of pro-
tein products that are surfactants (surface active 
substances) or possessing insurfactant properties 
(surface-inactive) in patients with LC provides the pro-
cesses of neoangiogenesis and the physicochemical 
interfacial state of blood serum [4]. There is a close 
intercommunication between the biochemical compo-
nents and the functional activity of the cells in tumor 
microenvironment, capable to secrete surfactants/
insurfactants influencing biochemical processes, and 
thus the adsorption-rheological properties of blood 
(ARPB) — surface tension (ST), serum viscosity (SV), 
serum elasticity (SE), serum relaxation (SR), and vis-
coelasticity (VE) modulus [5, 6].
The interfacial tensiometry method is used to study 
the ST of cancer cell cultures as a criterion of their 
aggressiveness [7, 8], as well as to evaluate the ef-
fect of antitumor drugs in vitro [6], in particular, in the 
context of the character of the drug load on cancer 
cells [9, 10]. It has been shown that the inhibitory ef-
fect on the viability of tumor cells occurs in the cases 
when ST of the culture medium decreased [11]. Taking 
into consideration the different activity of suspensions 
of normal and tumor cells at interphase (“blood”/ 
“air”), it is considered possible to selecting individual 
treatment of patients with LC on the basis of similar 
studies in vitro [12]. There is an opinion that ARPB 
can be used to monitor the effectiveness of antitumor 
radiochemotherapy [13].
The purposes and tasks of the study were to in-
vestigate the state of ARPB in patients with different 
variants of LC course, to determine the practical sig-
nificance of violations of surface-active, viscoelastic 
and relaxation properties of blood serum, their inter-
relationships with tumor markers, to evaluate the 
prognostic role of initial indices in the development 
of complications of radiochemotherapy.
MATERIALS AND METHODS
The work was carried out in accordance with the 
ethical norms set forth in the Declaration of the Hel-
sinki Medical Assembly, the patients gave informed 
consent for the study, which was approved by the 
commission on bioethics of the Donetsk National 
Medical University.
115 patients with LC aged 24 to 80 years (mean 
57.9 ± 1.1 years) were under the observation, among 
them there were 78.3% of men and 21.7% of women. 
None of the examined patients received previously 
surgical treatment of LC. Localization of LC was right-
sided in 59.1% of the cases, left-sided — in 38.3%, 
bilateral — in 2.6%; in the upper lobes of the lungs — 
in 23.5% of cases, in the lower lobes — in 13.9%, 
in the upper-lower-lobe on the left — in 19.1%, the 
middle-upper-lobe on the right — in 30.4%, the me-
diastinal — in 13.0%. The central form of LC occurred 
in 77.4% of cases, peripheral — in 22.6%.
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in 16.5% of cases, non-small cell histological vari-
ant of LC — in 83.5%, including adenocarcinoma — 
in 40.0%, squamous cell carcinoma — in 38.3%, large 
cell carcinoma — in 5.2%. IIIA stage of the tumor pro-
cess was observed in 12.2% of cases, IIIB — in 18.3%, 
IV — in 69.6%. The degree of differentiation of LC was 
1.15 ± 0.108 points, the staging — 6.57 ± 0.065 r.u., 
the integral severity index of tumor process (ISI) was 
3.97 ± 0.056 r.u., which was calculated by the formula: 
ISI = ln [T + N2 + (SM)2], 
where ln is the decimal logarithm, T is the inter-
national index of the primary tumor, N is the interna-
tional index of metastasis in regional lymph nodes, and 
SM is the sum of metastases in distant organs. The 
course of the disease in 12.2% of patients was compli-
cated by exudative pleurisy, in 11.3% — compression 
syndrome, 10.4% — tracheal invasion, in 5.2% — inva-
sion in the chest wall and compression of the recurrent 
nerve, in 4.4% — respectively obstructive atelectasis 
and compression of the upper vena cava, in 3.8% — 
tumor invasion in the esophagus, in 2.6% — in the ribs.
Metastatic spreading of LC to lymph nodes was 
found in 96.5% of observations, in distant organs — 
in 54.8%, in the skeleton — in 51.3%, and the average 
number of metastases per one patient was respectively 
2.42 ± 0.136 a.u., 1.86 ± 0.137 a.u. and 3.03 ± 0.192 a.u.
For the diagnosis of LC and its metastases, the meth-
ods of radiography, computed tomography, magnetic 
resonance imaging and sonography (Multix-Compact-
Siemens, Germany; Somazom-Emotion-6-Siemens, 
Germany; Gygoscan-Intera-Philips, Netherlands; 
Envisor-Philips, Netherlands), esophagogastroscopy 
(fibroscope Olympus-GIF-Q20, Japan) were used. The 
parameters of the blood (SV, SE, ST, SR, and VE) were 
assessed using a computer tensiometer PAT2-Sinterface 
(Germany), the volume viscosity of the blood (VV) was ex-
amined using a rotary viscosimeter Low-Shear-30 (Swit-
zerland). In our studies, a rapid stress deformation 
of the expansion of the blood serum surface was used 
(at t = 1200 s). The integral degree of change of ARPB 
(X) indices was determined by the formula:
2
1 ∑
n
i=1 SD
(М1 – М2)
n , 
where M1 is the index in the patient, M2 is the ave-
rage index in healthy persons of the control group, 
SD is the standard deviation of the index in healthy 
persons. The modified value was considered to be X 
> 2 r.u. As control, the parameters of ARPB were stu-
died in the blood serum of 50 practically healthy people 
aged 18 to 62 years (27 men and 23 women). Using 
immunoenzyme and biochemical methods (the reader 
PR2100-Sanofi Diagnostic Pasteur, France; Olympus-
AU640 Analyzer, Japan), the levels of TGFβ1, VEGF, os-
teopontin, osteocalcin, C-reactive protein, fibronectin 
and α2-macroglobulin in the blood serum were studied.
Statistical analysis of the data was carried out 
using computer variational, nonparametric, cor-
relative, regressive, one- (ANOVA) and multifactorial 
(ANOVA/MANOVA) dispersion analysis (Microsoft Ex-
cel and Statistica-Stat-Soft, USA). Mean values (M), 
their standard deviations (SD) and errors (m), 
Pearson’s correlation coefficients (r), regression 
criteria (R), dispersions of Brown — Forsythe (BF), 
Student (t), Wilcoxon — Rao (WR) and the reliability 
of statistical indices (p) were estimated. The values 
p < 0.05 were considered significant.
RESULTS AND DISCUSSION
The indices X > 2 r.u. were found in 20.9% of the 
patients with LC, which are conditionally included in the 
main group. If in healthy people the VV parameters 
were 1.3 ± 0.03 mPa•s, SV — 15.5 ± 0.23 mN/m, SE — 
42.8 ± 0.68 mN/m, ST — 42.8 ± 0.25 mN/m, SR — 
114.4 ± 3.03 s, VE — 23.7 ± 1.04 mN/m, the values of VV, 
SE, ST and SR were significantly higher in patients with 
LC, which (> M + SD healthy), were respectively detected 
in 100.0; 5.2; 18.3 and 16.5% of cases (Fig. 1, 2).
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Fig. 1. Histograms of the VV index in patients with LC (dark curve) 
and healthy people (light curve)
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Fig. 2. Histograms of the SR index in patients with LC (dark 
curve) and healthy people (light curve)
According to the findings of the multifactorial disper-
sion analysis of Wilcoxon — Rao, the localization of LC 
(WR = 1.58, p = 0.019), the presence of compression 
pulmonary syndrome (WR = 1.64, p = 0.013), the number 
of lymph node metastases per one patient (WR = 2.04, 
p = 0.001) and to distant organs (WR = 3.55, p < 0.001) 
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influence the integral state of ARPB. According to the 
Brown — Forsythe analysis, the parameters SV (BF = 2.69, 
p = 0.013), which in men proved to be significantly (by 8%) 
large (t = 2.87, p = 0.005) are associated with the sex of pa-
tients with LC. Indices of VV are affected by the small-cell 
form of LC (BF = 5.46, p = 0.021), the presence of com-
pression pulmonary syndrome (BF = 4.16, p = 0.044), 
adrenal metastases (BF = 6.99, p = 0.009) and the ribs 
(BF = 7.37, p = 0.008), the number of metastases in lymph 
nodes per a patient (BF = 5.39, p = 0.022), SV is af-
fected by development of exudative pleurisy (BF = 2.69, 
p = 0.013), tumor invasion in the ribs (BF = 3.33, p = 0.003) 
and meta stasis in the brain (BF = 2.74, p = 0.012), 
SE is affected by metastases in subclavian lymph nodes 
(BF = 1.79, p = 0.041), the sternum (BF = 1.82, p = 0.036), 
the humerus (BF = 2.60, p = 0.002) and the spinal column 
(BF = 3.20, p < 0.001), ST is affected by the index of dif-
ferentiation of LC (BF = 2,26, p = 0,047), SR is affected 
by metastases in the spine (BF = 4.61, p = 0.038) and pan-
creas (BF = 3.22, p < 0.001), VE is affected by metastases 
in the spine (BF = 1.74, p = 0.037) and non-small cell LC 
(BF = 2.34, p = 0.003).
Analysis of multiple regression showed a direct 
dependence of VV on the integral state of clinical signs 
of LC (R = +2.28, p = 0.025), and on the character of tu-
mor metastasis and the number of metastases in lymph 
nodes (R = +2.74, p = 0.007). VV directly correlates with 
ISI (r = +0.231, p = 0.013) and the number of metastases 
in the lymph nodes (r = +0.360, p < 0.001), and SR and 
VE values are inversely correlated with the number of me-
tastases in distant organs (r = −0.189, p = 0.043 and 
r = −0.238, p = 0.011), which is reflected in Fig. 3 and 4.
There are no correlations between separate indexes 
of ARPB and such tumor markers as osteopontin, os-
teocalcin and fibronectin. In turn, with all the parameters 
of ARPB without exception, there are direct relations 
between the level of VEGF, which, in addition to the 
prognostic factor of high aggression of LC [14–16], 
is an important component in the development of neo-
angiogenesis in such patients [17]. In addition to the 
above, VV positively correlates with TGFβ1 (r = +0.197, 
p = 0.035) and C-reactive protein (r = +0.293, p = 0.002), 
and ST and SR directly correlates with TGFβ1 (respec-
tively R = +0.209, p = 0.025 and r = +0.191, p = 0.042) 
and inversely with α2-macroglobulin (r = −0.190, 
p = 0.042 and r = −0.266, p = 0.004).
In deceased patients with X < 2 r.u. the life expec-
tancy was on average six months longer than in the main 
group of the examined persons, respectively amount-
ing to 11.3 ± 1.41 months and 17.9 ± 6.96 months, but 
the differences were unreliable. The life expectancy 
of such patients was influenced by the initial VV pa-
rameters (BF = 1.94, p = 0.018) and SV (BF = 1.71, 
p = 0.048), and a direct correlation was established 
with SE, ST and VE levels (r = +0.279, p = 0.007, 
r = +0.245, p = 0.019, r = +0.360, p < 0.001).
According to the results of ANOVA/MANOVA, the 
character of tumor metastasis in the lymph nodes 
(WR = 1.92, p = 0.048) and the skeleton (WR = 1.71, 
p = 0.049) affects the integral state of ARPB in patients 
with LC. As ANOVA shows, the number of metastases 
in the lymph nodes per one patient (correspondingly BF = 
3.79, p = 0.002 and BF = 3.30, p = 0.005) is related to the 
levels of VV and VE. In turn, the process of metastatic 
spreading in the bone is determined by the parameters 
of viscosity of blood (BF = 2.26, p = 0.043), and in dis-
tant organs — VE of the serum (BF = 2.93, p = 0.016). 
Correspondingly, ISI differently depends on VV and VE 
(R = +2.24, p = 0.027 and R = −2.42, p = 0.017, respec-
tively), metastatic spreading into the lymph nodes de-
pends only on VV (R = +3.65, p < 0.001), and metastatic 
spreading into distant organs depends on VE (R = −4.98, 
p < 0.001). Metastases in the osteoarticular apparatus 
are closely related to the relaxation properties of the 
blood (R = +3.30, p = 0.001). We suppose that the indices 
in the blood serum VV > 3.5 mPa•s (> M + SD patients) 
reflect the severity of the unfavorable course of LC.
Radical radiation therapy (RT) of the primary tu-
mor (> 60 Gy) was received by 5.2% of the number 
of examined patients, radical RT in combination with 
chemotherapy (CT) — 21.7%, palliative RT of the 
lungs — 10.4% of patients, palliative RT with CT — 
36.5%, palliative RT for distant metastases — 10.4%, 
palliative RT in combination with CT — 36.5%, pallia-
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Fig. 3. Correlation-regression relationships of the VV indica-
tion with the number of metastases in the lymph nodes of the 
patients with LC
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Fig. 4. Correlation-regression relations of the VE indication with 
the number of metastases in the distant organs of the patients 
with LC
tive RT for distant organs — 10.4%, in combination 
with CT — 15.7%. In general, RT was received by all 
patients, and CT was received by 85 (73.9%) of them. 
At the same time, the power of treatment was evalu-
ated. Thus, the average doses of chemotherapeutic 
drugs {< M + SD} were defined as minimal (1 point), 
the doses {M + SD   M + 2SD} — as moderate 
(2 points), {M + 2SD   M + 3SD} — as high (3 points) 
and {> M + 3SD} — as very high (4 points). The power 
of RT (W) and CT (Y) was calculated by the formula: 
W(Y) = (a + b + c + d) : n, 
where a, b, c, d — respectively the number of zones 
of irradiation or preparations in 1, 2, 3 and 4 points, 
n — the total number of irradiation zones and the 
total number of used drugs. The average parameters 
W were 1.39 ± 0.076 r.u., and Y — 0.37 ± 0.032 r.u.
As evidenced by the multifactorial analysis of Wil-
coxon — Rao, the character of complications of radio-
chemotherapy for LC is closely related to the overall 
condition of ARPB (WR = 4.57, p < 0.001). The number 
of complications from the treatment per a patient is sig-
nificantly influenced by the initial indices in blood VV 
(BF = 20.01, p < 0.001), SV (BF = 4.86, p = 0.001), SE 
(BF = 4. 20, p = 0.003), ST (BF = 6.31, p < 0.001), and 
SR (BF = 3.07, p = 0.020), it is demonstrated by ANO-
VA. At the same time, the values of VV have a dispersion 
effect on the development of radiation pneumofibrosis 
(BF = 5.06, p = 0.026), the formation of myelodepres-
sion (BF = 9.68, p = 0.002) and the appearance of acute 
disturbance of cerebral circulation of different degree 
of severity (BF = 27,77, p < 0.001), the parameters 
SE and SR — on the appearance of acute radiation 
pneumonitis (respectively, BF = 5.37, p = 0.022 and 
BF = 4.67, p = 0.033), ST and VE — on acute tubuloin-
terstitial nephritis (BF = 8.62, p = 0.004 and BF = 4.42, 
p = 0.038) and acute radiation esophagitis (BF = 8.12, 
p = 0.006 and BF = 8.21, p = 0.005).
Analysis of multiple regression shows a direct 
dependence of complications of RT and meta-
static spreading of tumor processes on the SV level 
(R = +3.98, p < 0.001) and feedback with VE (R = −3.33, 
p = 0.002). Taking into account the statistical process-
ing of the obtained data of the study, a conclusion has 
been made which has a practical focus: the indices of SV 
> 20 mN/m (> M + SD of patients) are prognostic-neg-
ative for possible complications of further radiotherapy 
of patients with LC.
CONCLUSIONS
RT in every fifth patient is accompanied by integral 
changes in ARPB, which are manifested by an increase 
of the levels of VV, SE, ST and SR, depending on the sex 
of patients (VE), tumor localization, its histological form, 
degree of differentiation and severity of the course (VV, 
ST, VE), the number of metastases in lymph nodes, 
distant organs and skeleton (VV, VE), involvement of the 
pleura and ribs in the process (SV), the development 
of compression lung syndrome (VV, SR), metastatic 
spreading in the spine (SE, SR, VE), adrenal glands, 
the brain (SV), and the pancreas (SR). Surface-active, 
viscoelastic and relaxation properties of blood correlate 
with the levels of tumor markers such as VEGF, TGFβ1, 
C-reactive protein, α2-macroglobulin, and indices 
VV and SV possess prognostic significance with respect 
to LC course and development of complications of ra-
diochemotherapy respectively.
REFERENCES
1. Ceniceros L, Aristu J, Castanon E, et al. Stereotactic 
body radiotherapy (SBRT) for the treatment of inoperable 
stage I non-small cell lung cancer patients. Clin Transl Oncol 
2015; 55: 213–9.
2. Grаdalska-Lampart M, Karczmarek-Borowska B, 
Radziszewska AU. Lung cancer in Podkarpackie region in the 
years 2002–2011. Pneumonol Alergol Pol 2015; 83: 109–19.
3. Yamada K, Maishi N, Akiyama K, et al. CXCL12-
CXCR7 axis is important for tumor endothelial cell angiogenic 
property. Int J Cancer 2015; 23: 172–8.
4. Zhou L, Pan Y, Xing Y, et al. Effects of Feijining Decoc-
tion on vascular endothelial growth factor protein expression 
and changes of T cell subsets in Lewis lung carcinoma-bearing 
mice. Biomed Rep 2015; 3: 403–7.
5. Giannopoulou E, Siatis KE, Metsiou D, et al. The in-
hibition of aromatase alters the mechanical and rheological 
properties of non-small-cell lung cancer cell lines affecting 
cell migration. Biochim Biophys Acta 2015; 1853: 328–37.
6. Rojewska M, Prochaska K, Olejnik A, Rychlik J. Adsorp-
tion properties of biologically active derivatives of quaternary 
ammonium surfactants and their mixtures at aqueous/air interface 
II. Dynamics of adsorption, micelles dissociation and cytotoxic-
ity of QDLS. Colloids Surf B Biointerfaces 2014; 119: 154–61.
7. Butler CM, Foty RA. Measurement of aggregate cohe-
sion by tissue surface tensiometry. J Vis Exp 2011; 50: 165–9.
8. Winters BS, Shepard SR, Foty RA. Biophysical measure-
ment of brain tumor cohesion. Int J Cancer 2015; 114: 371–9.
9. Laskar P, Samanta S, Ghosh SK, Dey J. In vitro evaluation 
of pH-sensitive cholesterol-containing stable polymeric micelles for 
delivery of camptothecin. J Colloid Interface Sci 2014; 430: 305–14.
10. Munyendo WL, Zhang Z, Abbad S, et al. Micelles 
of TPGS modified apigenin phospholipid complex for oral 
administration: preparation, in vitro and in vivo evaluation. 
J Biomed Nanotechnol 2013; 9: 2034–47.
11. Jiang L, Shen C, Long X, et al. Rhamnolipids elicit the 
same cytotoxic sensitivity between cancer cell and normal cell 
by reducing surface tension of culture medium. Appl Microbiol 
Biotechnol 2014; 98: 10187–96.
12. Preetha A, Banerjee R, Huilgol N. Dynamic surface 
tensiomeSRy of tissues using Langmuir films. Colloids Surf 
B Biointerfaces 2015; 40: 35–43.
13. Bloy N, Pol J, Manic G, et al. Radioimmunotherapy 
for oncological indications. Oncoimmunology 2014; 3: 954929.
14. Domigan CK, Warren CM, Antanesian V, et al. Auto-
crine VEGF maintains endothelial survival through regulation 
of metabolism and autophagy. J Cell Sci 2015; 128: 2236–48.
15. Lin Q, Xue L, Tian T, et al. Prognostic value of serum 
IL-17 and VEGF levels in small cell lung cancer. Int J Biol 
Markers 2015; 30: 165–75.
16. Ostheimer C, Bache M, Güttler A, et al. Prognostic infor-
mation of serial plasma osteopontin measurement in radiotherapy 
of non-small-cell lung cancer. BMC Cancer 2014; 21: 858–65.
17. Akin Kabalak P, Çiledag A, Demir N, et al. Prognostic sig-
nificance of serum vascular endothelial growth factor and angiopoi-
etin-2 in patients with lung cancer. Tuberk Toraks 2015; 63: 71–7.
Copyright © Experimental Oncology, 2017
